Office of the Director, National Institutes of Health; Notice of Meeting, 71071-71072 [2021-26988]
Download as PDF
<![CDATA[
71071
Federal Register / Vol. 86, No. 237 / Tuesday, December 14, 2021 / Notices
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN—CENTER FOR BIOLOGICS EVALUATION AND RESEARCH 1
Number of
responses per
respondent
Number of
respondents
21 CFR part 312, subpart I; information collection activity
§§ 312.310(b) and 312.305(b); number of submissions related to expanded access and treatment of an individual patient: Form FDA 3926 ..........................
§ 312.310(d); number of submissions related to emergency use of an investigational new drug: Form FDA 3926 ......................................................................
§§ 312.315(c) and 312.305(b); number of submissions related to expanded access and treatment of an intermediate-size patient population 2 ......................
§ 312.320(b); number of submissions related to a treatment IND or treatment
protocol 2 ............................................................................................................
Total ...............................................................................................................
Total
annual
responses
Average
burden per
response
Total hours
118
1.305
154
8
1,232
1,591
4.2137
6,704
16
107,264
28
1
28
120
3,360
15
1
15
300
4,500
........................
........................
6,901
........................
116,356
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
2 Data elements are reported in Forms FDA 1571 and 1572, approved under OMB control number 0910–0014.
The information collection reflects an
increase in 254,750 burden hours and
11,568 responses annually since the last
OMB review and approval of the
information collection. We attribute this
to an increase in the number of
submission.
MD 20892, (301) 402–4411, tianbi@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 8, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–26990 Filed 12–13–21; 8:45 am]
Dated: December 9, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4164–01–P
[FR Doc. 2021–27020 Filed 12–13–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Visual
Cortex Perception.
Date: January 5, 2022.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
VerDate Sep<11>2014
18:24 Dec 13, 2021
Jkt 256001
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Study Section.
Date: February 28–March 1, 2022.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Contact Person: Anna Ghambaryan, M.D.,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2120, MSC 6902, Bethesda, MD
20892, 301–443–4032, anna.ghambaryan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: December 9, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–27021 Filed 12–13–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Council of Councils.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
E:\FR\FM\14DEN1.SGM
14DEN1
71072
Federal Register / Vol. 86, No. 237 / Tuesday, December 14, 2021 / Notices
jspears on DSK121TN23PROD with NOTICES1
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: January 27, 2022.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; NIH Program
Updates; Scientific Talks and Other Business
of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Name of Committee: Council of Councils.
Closed: January 28, 2022.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Open: January 28, 2022.
Time: 11:15 a.m. to 3:00 p.m.
Agenda: NIH Program Updates; Scientific
Talks and Other Business of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Robert W. Eisinger, Ph.D.,
Executive Secretary, Council of Councils,
Senior Scientific Advisor, Division of
Program Coordination, Planning, and
Strategic Initiatives, Office of the Director,
NIH, Building 1, Room 258, One Center
Drive, Bethesda, MD 20892, robert.eisinger@
nih.gov, 301–451–0455.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: December 8, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–26988 Filed 12–13–21; 8:45 am]
18:24 Dec 13, 2021
Coast Guard
[Docket No. USCG–2021–0630; OMB
Control Number 1625–0088]
Collection of Information Under
Review by Office of Management and
Budget
AGENCY:
Coast Guard, DHS.
Thirty-day notice requesting
comments.
ACTION:
In compliance with the
Paperwork Reduction Act of 1995 the
U.S. Coast Guard is forwarding an
Information Collection Request (ICR),
abstracted below, to the Office of
Management and Budget (OMB), Office
of Information and Regulatory Affairs
(OIRA), requesting an extension of its
approval for the following collection of
information: 1625–0088, Voyage
Planning for Tank Barge Transits in the
Northeast United States; without
change. Our ICR describes the
information we seek to collect from the
public. Review and comments by OIRA
ensure we only impose paperwork
burdens commensurate with our
performance of duties.
SUMMARY:
You may submit comments to
the Coast Guard and OIRA on or before
January 13, 2022.
DATES:
Comments to the Coast
Guard should be submitted using the
Federal eRulemaking Portal at https://
www.regulations.gov. Search for docket
number [USCG–2021–0630]. Written
comments and recommendations to
OIRA for the proposed information
collection should be sent within 30 days
of publication of this notice to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function.
A copy of the ICR is available through
the docket on the internet at https://
www.regulations.gov. Additionally,
copies are available from: Commandant
(CG–6P), ATTN: Paperwork Reduction
Act Manager, U.S. Coast Guard, 2703
Martin Luther King Jr. Ave. SE, STOP
7710, Washington, DC 20593–7710.
ADDRESSES:
A.L.
Craig, Office of Privacy Management,
telephone 202–475–3528, or fax 202–
372–8405, for questions on these
documents.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
BILLING CODE 4140–01–P
VerDate Sep<11>2014
DEPARTMENT OF HOMELAND
SECURITY
Jkt 256001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Public Participation and Request for
Comments
This notice relies on the authority of
the Paperwork Reduction Act of 1995;
44 U.S.C. 3501 et seq., chapter 35, as
amended. An ICR is an application to
OIRA seeking the approval, extension,
or renewal of a Coast Guard collection
of information (Collection). The ICR
contains information describing the
Collection’s purpose, the Collection’s
likely burden on the affected public, an
explanation of the necessity of the
Collection, and other important
information describing the Collection.
There is one ICR for each Collection.
The Coast Guard invites comments on
whether this ICR should be granted
based on the Collection being necessary
for the proper performance of
Departmental functions. In particular,
the Coast Guard would appreciate
comments addressing: (1) The practical
utility of the Collection; (2) the accuracy
of the estimated burden of the
Collection; (3) ways to enhance the
quality, utility, and clarity of
information subject to the Collection;
and (4) ways to minimize the burden of
the Collection on respondents,
including the use of automated
collection techniques or other forms of
information technology. These
comments will help OIRA determine
whether to approve the ICR referred to
in this Notice.
We encourage you to respond to this
request by submitting comments and
related materials. Comments to Coast
Guard or OIRA must contain the OMB
Control Number of the ICR. They must
also contain the docket number of this
request, [USCG–2021–0630], and must
be received by January 13, 2022.
Submitting Comments
We encourage you to submit
comments through the Federal
eRulemaking Portal at https://
www.regulations.gov. If your material
cannot be submitted using https://
www.regulations.gov, contact the person
in the FOR FURTHER INFORMATION
CONTACT section of this document for
alternate instructions. Documents
mentioned in this notice, and all public
comments, are in our online docket at
https://www.regulations.gov and can be
viewed by following that website’s
instructions. Additionally, if you go to
the online docket and sign up for email
alerts, you will be notified when
comments are posted.
We accept anonymous comments. All
comments to the Coast Guard will be
posted without change to https://
www.regulations.gov and will include
any personal information you have
E:\FR\FM\14DEN1.SGM
14DEN1
]]>Agencies
[Federal Register Volume 86, Number 237 (Tuesday, December 14, 2021)]
[Notices]
[Pages 71071-71072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26988]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Council of
Councils.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The open session will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov).
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4), and 552b(c)(6),
Title 5
[[Page 71072]]
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Open: January 27, 2022.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: Call to Order and Introductions; Announcements and
Updates; NIH Program Updates; Scientific Talks and Other Business of
the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Name of Committee: Council of Councils.
Closed: January 28, 2022.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Open: January 28, 2022.
Time: 11:15 a.m. to 3:00 p.m.
Agenda: NIH Program Updates; Scientific Talks and Other Business
of the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert W. Eisinger, Ph.D., Executive Secretary,
Council of Councils, Senior Scientific Advisor, Division of Program
Coordination, Planning, and Strategic Initiatives, Office of the
Director, NIH, Building 1, Room 258, One Center Drive, Bethesda, MD
20892, [email protected], 301-451-0455.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council of Council's home
page at https://dpcpsi.nih.gov/council/ where an agenda will be
posted before the meeting date.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: December 8, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-26988 Filed 12-13-21; 8:45 am]
BILLING CODE 4140-01-P
